Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Congestive Heart Failure
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Congestive Heart Failure
    TopAbstracts in Congestive Heart Failure 02/04/2010 - (DGNews)
    TopAbstracts in Congestive Heart Failure 01/26/2010 - (DGNews)
    FDA Approves Left Ventricular Assist System for Severe Heart Failure Patients - (DGNews)
    TopAbstracts in Congestive Heart Failure 01/07/2010 - (DGNews)
    Ipratropium Bromide May Increase Risk for Cardiovascular Events - (DGNews)

    News archive

     Recent webcasts/CME - Congestive Heart Failure
    • What Clinicians Need To Know About Antiplatelet Therapy and Managing Acute Coronary Syndrome: A Roundtable Discussion
    • And the Survey Says: What Do Clinicians Need To Know About Managing Their Patients With ACS?
    • Optimal Duration and Risks of Antiplatelet Therapy: What Have We Learned?
    • Emerging Trends in the Management of Arrhythmias and Pump Failure in Patients with Advanced HF
      Future Direction of Stem Cells in Cardiovascular Disease

      Webcasts/CME archive

       Recent cases - Congestive Heart Failure
        Congestive Heart Failure
        Spontaneous Left Main Coronary Artery Dissection Complicated by Pseudoaneurysm Formation in Pregnancy: Role of CT Coronary Angiography
        Cardiogenic Shock as a Complication of Acute Mitral Valve Regurgitation Following Posteromedial Papillary Muscle Infarction in the Absence of Coronary Artery Disease
        Hyperthyroidism as a Reversible Cause of Right Ventricular Overload and Congestive Heart Failure
        Congestive Cardiac Failure and Anemia in a 15-Year-Old Boy

        Cases archive
          




        my personal edition > congestive heart failure > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Even 'High Normal' Glucose May Increase Risk of Hospitalization for Heart Failure

        DALLAS, TX -- March 7, 2007 -- Fasting glucose levels may independently predict the risk of being hospitalized with congestive heart failure in heart attack survivors and others who are at high risk of developing the disorder, researchers reported in Circulation: Journal of the American Heart Association.

        Drawing on data from 31,546 high-risk patients participating in two international trials, researchers found that even small increases in fasting glucose raised the risk of congestive heart failure in both diabetes patients and those whose blood sugar fell within the normal range.

        "This illustrates that blood glucose by itself is a continuous risk factor for developing heart failure because all of these patients were free of heart failure when they enrolled in the trials," said Claes Held, MD, PhD, lead author of the study.

        "However, these are only associations," said Held, an associate professor of cardiology at the Karolinska Institutet in Stockholm, Sweden. "They do not prove that elevated blood glucose causes heart failure. To demonstrate a causal relationship, you would have to do a study that showed lowering blood glucose levels would reduce the incidence of heart failure."

        To examine the relationship between blood glucose levels and congestive heart failure, Held and colleagues performed an interim analysis on the blinded data from the ONgoing Telmisartan Alone and in combination with the Ramipril Global Endpoint Trial (ONTARGET) and Telmisartan Randomized AssessmeNt Study in aCE iNtolerant subjects with cardiovascular Disease (TRANSCEND) trials. Both were randomized, controlled, parallel clinical studies testing drug regimens aimed at reducing fatal and nonfatal cardiovascular events. ONTARGET had 25,620 patients enrolled and TRANSCEND had 5,926, and both included patients with and without diabetes. Researchers obtained fasting blood glucose levels for patients when they entered the trials and periodically thereafter.

        "We know that diabetes is a strong risk factor for cardiovascular disease including heart failure, but these studies included patients with and without diabetes," Held said. "This was a great opportunity to evaluate a broad population of high-risk individuals and study the association between blood glucose and cardiovascular disease, regardless of the diabetic state."

        Patients in the two trials were average age 67 at entry, and 69 percent were men. Thirty-seven percent had been previously diagnosed with diabetes and 3.2% were diagnosed with the disease at the time of entry.
        Patients were assigned to five groups based on their entry fasting blood glucose levels, measured in millimoles per liter of blood, or mmol/L. The lowest group had an average fasting blood glucose of 4.6 mmol/L and the highest had an average reading of 8.5 mmol/L.

        The mmol/L is the international standard unit for measuring blood glucose. In the United States, blood glucose levels are usually reported in milligrams per deciliter, mg/dL. Multiplying the number of mmol/L by 18 converts the number to mg/dl.

        Researchers analyzed data from patients with an average follow-up of 2.4 years. During this time there were:
        · 1,067 cardiovascular deaths
        · 926 heart attacks
        · 823 strokes
        · 668 hospitalizations for congestive heart failure

        When the researchers examined fasting blood glucose levels alone as a risk factor by adjusting for other known risk factors, they found that, for all patients, an increase of 1 mmol/L above a patient's entry glucose level increased the risk of hospitalization for congestive heart failure by 5%.

        Similarly, a 1 mmol/L rise increased the risk of congestive heart failure hospitalization or cardiovascular death by 9% for all patients, by 3% for patients without diabetes and by 5% for patients with diabetes.

        "Even in the normal range, our results indicate that elevated blood glucose is associated with the risk of heart failure," Held said. "You can look at blood glucose much like blood pressure or cholesterol. Even if you have normal blood glucose, there is a gradual increase in risk wherever you start on the scale. If the blood sugar is "high normal" there is a higher risk than those with "low normal fasting blood glucose levels."

        He and colleagues suggested several potential mechanisms for rising glucose levels which increase the risk of developing congestive heart failure.

        "Individuals with disturbances in their glucose regulation usually have more coronary artery disease, which is a well known underlying risk factor for heart failure," Held said. "That is a strong explanation for our findings but the others are more speculative and hypothetical."


        SOURCE: American Heart Association



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send